At the end of the review, the US FDA issued a Form 483 with four observations. These relate to enhancements in procedures and are expected to be classified as VAI, or voluntary action indicated.
Tokyo’s Nikkei 225 outperformed the region in morning trade, climbing 1% as shares in Softbank Group surged 6% after Bloomberg News reported it is considering acquiring the U.S. data centre company Switch Inc.
Sensex Today | Stock Market LIVE Updates: Thursday’s high of 25,922 will be key on the upside for the index, while 25,700 will mostly be a key support. The depreciating rupee is back in the spotlight with the currency hitting…
Lower-than-expected AI product backlog, coupled with no 2026 guidance for AI product sales were some of the factors that displeased Broadcom investors, despite better-than-expected Q4 results and Q1 guidance.
A firm called Interactive Brokers expects the S&P 500 to stage a Santa Claus rally and break past the 7,000 mark this year itself. However, it has set a 2026-end target of just 6,500, projecting downside for the index, as…
The ICICI Prudential AMC IPO is India’s fourth largest IPO of 2025, following Tata Capital, HDB Financial and LG Electronics India. At ₹10,602 crore, the issue is a complete offer for sale, with Prudential being the selling shareholder.
Ramesh Damani says Berkshire Hathaway’s multi-decade rise offers Indian investors a clear blueprint for wealth creation—one built not on market timing, but on allowing high-quality businesses to compound over generations. Drawing on personal anecdotes and historical market data, he argues…
Yes Bank, Tata Power, Vedanta, Tata Steel, and others announce key acquisitions, expansions, and leadership changes. Here are few stocks to watch ahead of Friday’s trading session.
Raamdeo Agrawal recounts how a single Berkshire Hathaway annual report upended his understanding of investing and pushed him towards concentrated bets. His early missteps, including exiting future multibaggers too soon, now serve as reminders of why discipline, quality and long-term…
Piramal Pharma Ltd received a US FDA Form 483 with four observations at its Lexington facility, expected as VAI. The company will respond and aims to uphold quality and compliance.